Akebia Therapeutics reported $-59959000 in Pre-Tax Profit for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -42M 47M
Acceleron Pharma XLRN:US $ -19M 32M
Akebia Therapeutics AKBA:US $ -59.96M 0.26M
Alexion Pharmaceuticals ALXN:US $ 827.7M 41M
Alnylam Pharmaceuticals ALNY:US $ -252.45M 74.23M
Amgen AMGN:US $ 2918M 77M
Ardelyx ARDX:US $ -25M 2M
AstraZeneca AZN:LN 1478M 114M
Bayer BAYN:GR € 2049M 933M
Biomarin Pharmaceutical BMRN:US $ -15.97M 117.32M
Exelixis EXEL:US $ 80M 20M
Fresenius Medical Care FME:GR € 564M 113M
GlaxoSmithKline GSK:LN 1541M 956M
Intercept Pharmaceuticals ICPT:US $ -63.28M 29.7M
Johnson & Johnson JNJ:US $ 7246M 1909M
Opko Health OPK:US $ 20.6M 19.32M
Prothena PRTA:US $ -30.79M 4.26M
Ptc Therapeutics PTCT:US $ -170.73M 58.26M
Regeneron Pharmaceuticals REGN:US $ 876M 24.6M
Sanofi SAN:FP € 2054M 276M
Sarepta Therapeutics SRPT:US $ -151M 133M
Seattle Genetics SGEN:US $ 639.41M 660.6M
Vanda Pharmaceuticals VNDA:US $ 11.09M 9.85M